REFERENCES
- Schooley RT. Antiretroviral chemotherapy. In: Wormser GP, ed. AIDS and other manifestations of HIV infection, 3rd ed. Philadelphia, PA: Lippincott-Raven, 1998: 717–32.
- Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng T-C, et al. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. N Engl J Med 1995; 333: 401–7.
- Murray HW, Squires KE, Weiss W, Sledz S, Sacks HS, Hasset J, et al. Stavudine in patients with AIDS and AIDS-related complex: AIDS Clinical Trials Group 089. J Infect Dis 1995;171 (Suppl 2): S123–30.
- Ahmad S, Sukthankar A. Stavudine induced macrocytosis. Genitourinary Med 1997; 73: 412–23.
- Genne D, Goehring C, Saaidia A, Anwar D, Hirschel B. Macrocytosis in patients with HIV infection: after zidovudine. 12th World AIDS Conference, Geneva, 1998: Abstract no. 32156.
- Kahn JO, Lagakos SW, Richman DD, Cross A, Pettinelli C, Liou S-H, et al. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med 1992; 327: 581–7.
- Vella S, Floridia M, Dally LG, Tomino C, Fragola V, Weimer LE, et al. A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS. J Acquir Immune Defic Syndr 1996; 12: 462–9.
- Walker RE, Parker RI, Kovaks JA, Masur H, Lane HC, Carleton S, et al. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi Sarcoma treated with zidovudine. Ann Intern Med 1988; 108: 372–6.